Data / Drug companies / Laboratorio MK SRL
Laboratorio MK SRL: 10 products in the FDA NDC directory, labeler code 87022
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Laboratorio MK SRL (labeler code 87022) lists 10 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 10 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 2, 2025.
The request: Watch Laboratorio MK SRL (FDA labeler code 87022): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 87022
- Products in commercial distribution
- 10
- Packages
- 11
- Finished drugs by generic name
- 1
- Prescription products
- 0
- Over the counter products
- 10
- Flagged as original packager
- 10 of 10 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 10
- Earliest marketing start
- August 13, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 10 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 10 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Minoxidil | 10 | 113 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 4 | 40% |
| Liquid | 3 | 30% |
| Rinse | 2 | 20% |
| Shampoo | 1 | 10% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Arteriolar Vasodilator | 10 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Aromatica hair gota de brillo romero con minoxidil | 87022-015 | Liquid | Over the counter monograph drugs | October 2, 2025 |
| Aromatica hair leave in romero con minoxidil | 87022-016 | Cream | Over the counter monograph drugs | October 1, 2025 |
| Aromatica hair tratamiento romero con minoxidil | 87022-013 | Cream | Over the counter monograph drugs | October 1, 2025 |
| Aromatica hair acondicionador romero con minoxidil | 87022-012 | Rinse | Over the counter monograph drugs | October 1, 2025 |
| Aromatica hair champu | 87022-011 | Shampoo | Over the counter monograph drugs | September 26, 2025 |
| Hair leave in | 87022-010 | Cream | Over the counter monograph drugs | August 22, 2025 |
| Hair treatment | 87022-009 | Cream | Over the counter monograph drugs | August 22, 2025 |
| Hair acondicionador | 87022-008 | Rinse | Over the counter monograph drugs | August 22, 2025 |
| Hair champu | 87022-007 | Liquid | Over the counter monograph drugs | August 20, 2025 |
| Hair growth solution | 87022-006 | Liquid | Over the counter monograph drugs | August 13, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.